The Europe multiplex assay market is projected to grow with a CAGR of 8.37% over the forecasting years of 2021 to 2028. The market growth of the region is primarily attributed to the rising focus of the European government towards technological advancements in terms of medical devices, the increase in healthcare expenditure, the presence of well-established healthcare systems, and the surging geriatric populace.
EUROPE MULTIPLEX ASSAY MARKET FORECAST 2021-2028
Europe Multiplex Assay Market by Type ( Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Multiplex Assays ) Market by Product ( Reagents and Consumables, Instruments and Accessories, Software and Services ) Market by Technology ( Multiplex Protein Microarray, Multiplex Pcr, Other Technologies ) Market by Application ( Clinical Diagnostics, Research and Development, Companion Diagnostics ) Market by End-user ( Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies ) by Geography.
The Europe multiplex assay market is projected to grow with a CAGR of 8.37% over the forecasting years of 2021 to 2028. The market growth of the region is primarily attributed to the rising focus of the European government towards technological advancements in terms of medical devices, the increase in healthcare expenditure, the presence of well-established healthcare systems, and the surging geriatric populace.
To know more about this report, request a free sample copy.
The Europe multiplex assay market growth evaluation includes the assessment of Russia, Belgium, France, Poland, the United Kingdom, Italy, Germany, and the rest of Europe. The United Kingdom harbors a well-established healthcare system, as well as an augmenting healthcare industry. As a result, the country’s market continues to experience rapid growth. In addition, the increasing government initiatives to facilitate genomic and clinical research play a vital role in influencing the demand for multiple assays in the United Kingdom.
On the other hand, the France multiplex assay market is predominantly fueled by the developments observed in the genome sector, the programs associated with the development of multiplex assay, and clinical trials. Furthermore, the French government began the Strategic Industrial Innovation Program that promotes academic and industrial collaborations in order to boost the discovery of advanced technologies and products through funding from public institutions. Therefore, the aforementioned drivers are set to reinforce the multiplex assay market growth in Europe during the forecast period.
Hoffmann-La Roche, headquartered in Switzerland, is a healthcare firm that commercializes and develops innovative diagnostic and therapeutic products. It researches and manufactures pharmaceutical products across multiple therapeutic areas, including infectious diseases, neuroscience, oncology, ophthalmology, and immunology. The company also distributes hematology and hemostasis products, immunoassays, laboratory automation, clinical chemistry, patient self-testing products, IT solutions, and urinalysis products.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
- ADOPTION OF PERSONALIZED MEDICINES
- KEY RESTRAINTS
- UNAVAILABILITY OF SKILLED LAB TECHNICIANS
- COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATION
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY TYPE
- PROTEIN-BASED MULTIPLEX ASSAY
- NUCLEIC ACID-BASED MULTIPLEX ASSAY
- OTHER MULTIPLEX ASSAYS
- MARKET BY PRODUCT
- REAGENTS AND CONSUMABLES
- INSTRUMENTS AND ACCESSORIES
- SOFTWARE AND SERVICES
- MARKET BY TECHNOLOGY
- MULTIPLEX PROTEIN MICROARRAY
- MULTIPLEX PCR
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- CLINICAL DIAGNOSTICS
- RESEARCH AND DEVELOPMENT
- COMPANION DIAGNOSTICS
- MARKET BY END-USER
- HOSPITALS
- CLINICAL LABORATORIES
- RESEARCH INSTITUTES
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ABCAM
- AGILENT TECHNOLOGIES INC
- BECTON, DICKINSON AND COMPANY (BD)
- BIO-RAD LABORATORIES INC
- BIO-TECHNE CORPORATION
- HOFFMANN-LA ROCHE
- ILLUMINA INC
- LUMINEX CORPORATION
- MERCK MILLIPORE
- OLINK PROTEOMICS AB
- QIAGEN NV
- RANDOX LABORATORIES LTD
- SEEGENE INC
- SIEMENS HEALTHINEERS AG
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY
TABLE 2: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN THE EUROPE MULTIPLEX ASSAY MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
FIGURE 6: EUROPE MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
FIGURE 10: EUROPE MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
FIGURE 14: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 17: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
FIGURE 19: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
FIGURE 23: EUROPE MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 26: EUROPE MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 28: GERMANY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: FRANCE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: ITALY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: RUSSIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: BELGIUM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: POLAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- MARKET BY TYPE
- PROTEIN-BASED MULTIPLEX ASSAY
- NUCLEIC ACID-BASED MULTIPLEX ASSAY
- OTHER MULTIPLEX ASSAYS
- MARKET BY PRODUCT
- REAGENTS AND CONSUMABLES
- INSTRUMENTS AND ACCESSORIES
- SOFTWARE AND SERVICES
- MARKET BY TECHNOLOGY
- MULTIPLEX PROTEIN MICROARRAY
- MULTIPLEX PCR
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- CLINICAL DIAGNOSTICS
- RESEARCH AND DEVELOPMENT
- COMPANION DIAGNOSTICS
- MARKET BY END-USER
- HOSPITALS
- CLINICAL LABORATORIES
- RESEARCH INSTITUTES
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.